TNF and type 2 diabetes mellitus: Treatment with pentoxifylline, a drug that can inhibit TNFα production, significantly reduced albuminuria and slowed estimated glomerular filtration ratio (eGFR) decline in patients with type 2 diabetes (T2D) and stage 3–4 CKD2.